Regulatory B cells: TIM‐1, transplant tolerance, and rejection
Open Access
- 22 January 2021
- journal article
- review article
- Published by Wiley in Immunological Reviews
- Vol. 299 (1), 31-44
- https://doi.org/10.1111/imr.12933
Abstract
Regulatory B cells (Bregs) ameliorate autoimmune disease and prevent allograft rejection. Conversely, they hinder effective clearance of pathogens and malignancies. Breg activity is mainly attributed to IL‐10 expression, but also utilizes additional regulatory mechanisms such as TGF‐β, FasL, IL‐35, and TIGIT. Although Bregs are present in various subsets defined by phenotypic markers (including canonical B cell subsets), our understanding of Bregs has been limited by the lack of a broadly inclusive and specific phenotypic or transcriptional marker. TIM‐1, a broad marker for Bregs first identified in transplant models, plays a major role in Breg maintenance and induction. Here, we expand on the role of TIM‐1+ Bregs in immune tolerance and propose TIM‐1 as a unifying marker for Bregs that utilize various inhibitory mechanisms in addition to IL‐10. Further, this review provides an in‐depth assessment of our understanding of Bregs in transplantation as elucidated in murine models and clinical studies. These studies highlight the major contribution of Bregs in preventing allograft rejection, and their ability to serve as highly predictive biomarkers for clinical transplant outcomes.Keywords
Funding Information
- National Institutes of Health (P01 AI129880, R01 AI114587)
This publication has 111 references indexed in Scilit:
- Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors RORγt and Ahr that leads to IL-17 production by activated B cellsNature Immunology, 2013
- Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactionsNature, 2012
- Defect in regulatory B-cell function and development of systemic autoimmunity in T-cell Ig mucin 1 (Tim-1) mucin domain-mutant miceProceedings of the National Academy of Sciences of the United States of America, 2012
- B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cellsThe Journal of Experimental Medicine, 2012
- Potent Induction Immunotherapy Promotes Long-Term Insulin Independence After Islet Transplantation in Type 1 DiabetesAmerican Journal of Transplantation, 2012
- B regulatory cells and the tumor-promoting actions of TNF-α during squamous carcinogenesisProceedings of the National Academy of Sciences of the United States of America, 2011
- A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory ResponsesImmunity, 2008
- Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft toleranceProceedings of the National Academy of Sciences of the United States of America, 2007
- Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cellsProceedings of the National Academy of Sciences of the United States of America, 2007
- Differential engagement of Tim-1 during activation can positively or negatively costimulate T cell expansion and effector functionThe Journal of Experimental Medicine, 2007